These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 759958)

  • 1. DNA critics appointed to advisory committee.
    Nature; 1979 Jan; 277(5692):83. PubMed ID: 759958
    [No Abstract]   [Full Text] [Related]  

  • 2. US expected to exempt most recombinant DNA experiments from federal regulation.
    Nature; 1979 Sep; 281(5727):90. PubMed ID: 471066
    [No Abstract]   [Full Text] [Related]  

  • 3. US drug companies push for changes in recombinant DNA guidelines.
    Dickson D
    Nature; 1979 Mar; 278(5703):385-6. PubMed ID: 450039
    [No Abstract]   [Full Text] [Related]  

  • 4. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003.
    National Institutes of Health Recombinant DNA Advisory Committee
    Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317
    [No Abstract]   [Full Text] [Related]  

  • 5. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting, January 30, 1989.
    Recomb DNA Tech Bull; 1989 Jun; 12(2):69-134. PubMed ID: 2595015
    [No Abstract]   [Full Text] [Related]  

  • 6. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 7. US to increase public participation in regulation of DNA research.
    Dickson D
    Nature; 1978 Nov; 276(5687):430. PubMed ID: 723919
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health.
    Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602
    [No Abstract]   [Full Text] [Related]  

  • 9. Protect NIH's DNA advisory committee.
    Adelman ZN; Albritton LM; Boris-Lawrie K; Buchmeier MJ; Cannon P; Cho M; DiGiusto D; Donahue JK; Federoff HJ; Hammarskjold ML; Hardison AD; Hearing P; Lee B; Lee DA; Porteus MH; Ross LF; Ross SR; Wooley DP; Zoloth L
    Science; 2018 Oct; 362(6413):409-410. PubMed ID: 30361364
    [No Abstract]   [Full Text] [Related]  

  • 10. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA guidelines for further attenuation.
    Dickson D
    Nature; 1981 Mar; 290(5804):281. PubMed ID: 7207619
    [No Abstract]   [Full Text] [Related]  

  • 12. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Human Gene Therapy Subcommittee. Minutes of meeting, December 9, 1988.
    Recomb DNA Tech Bull; 1989 Mar; 12(1):29-45. PubMed ID: 2657876
    [No Abstract]   [Full Text] [Related]  

  • 13. The revised "Points to Consider" document.
    Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA guidelines. More relaxation.
    Dickson D
    Nature; 1980 Oct; 287(5781):380-1. PubMed ID: 6933313
    [No Abstract]   [Full Text] [Related]  

  • 15. RAC approves accelerated review!
    Anderson WF
    Hum Gene Ther; 1994 Jun; 5(6):665-6. PubMed ID: 7948128
    [No Abstract]   [Full Text] [Related]  

  • 16. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Points to Consider Subcommittee. Minutes of meeting, March 31, 1989.
    Recomb DNA Tech Bull; 1989 Sep; 12(3):151-70. PubMed ID: 2595016
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant DNA research: the scope and limits of regulation.
    Krimsky S; Ozonoff D
    Am J Public Health; 1979 Dec; 69(12):1252-9. PubMed ID: 507257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 20. New rules for gene-therapy pioneers.
    New Sci; 1984 Jan; 101(1392):7. PubMed ID: 11655580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.